Incyte Corporation INCY NASDAQ

#	姓名	职位	持股数量	最近申报日期	相对规模
1	Baker Felix	Director	2,944,621	2022-10-04	100%
2	Baker Bros. Advisors Lp	10 Percent Owner	2,818,039	2026-04-02	96%
3	Hoppenot Herve	Director	326,803	2025-12-10	11%
4	Stamoulis Christiana	EVP & Chief Financial Officer	110,123	2025-04-03	4%
5	Swain Paula J	EVP, Human Resources	96,362	2025-04-03	3%
6	Flannelly Barry P	EVP & General Manager Us	44,726	2025-04-03	2%
7	Iyengar Vijay K	EVP, Gmapps	41,817	2025-04-03	1%
8	Heeson Lee	EVP, Head of Incyte Intl	38,041	2026-02-04	1%
9	Dickinson Jonathan Elliott	EVP, General Manager, Europe	36,390	2024-09-16	1%
10	Morrissey Michael James	EVP, Head of Tech. Operations	34,065	2026-02-04	1%
11	Clancy Paul J	Director	23,741	2026-04-02	1%
12	Harrigan Edmund	Director	21,122	2026-04-02	1%
13	Pasquale Maria E	EVP & General Counsel	20,275	2023-07-18	1%
14	Stein Steven H	EVP & Chief Medical Officer	19,932	2026-01-21	1%
15	Dixon Wendy L	Director	17,768	2022-04-04	1%
16	Dhanak Dashyant	EVP & Chief Scientific Officer	16,896	2023-07-18	1%
17	Wenqing Yao	EVP, Head of Discovery Chem	15,054	2021-07-07	1%
18	Trotta Matteo	EVP, GM, Dermatology Us	14,882	2026-03-26	1%
19	Issa Mohamed Khairie	EVP, Head of Us Oncology	14,237	2026-01-21	0%
20	Friedman Paul A	Director	10,514	2020-05-28	0%

近期交易 (过去12个月)

日期	姓名	职位	类型	股数	股价	总价值
2026-03-31	Clancy Paul J	Director	限制性股票授予 (RSU)	265	$94.12	$24.94K
2026-03-31	Baker Bros. Advisors Lp	10 Percent Owner	限制性股票授予 (RSU)	421	-	-
2026-03-31	Harrigan Edmund	Director	限制性股票授予 (RSU)	269	$94.12	$25.32K
2026-03-25	Trotta Matteo	EVP, GM, Dermatology Us	RSU 预扣税	537	$92.23	$49.53K
2026-03-17	Cagnoni Pablo J	President, R&d	期权行权（卖出）	7,166	$61.18	$438.42K
2026-02-19	Cagnoni Pablo J	President, R&d	期权行权（卖出）	13,093	$61.76	$808.62K
2026-02-02	Heeson Lee	EVP, Head of Incyte Intl	RSU 预扣税	111	$102.67	$11.4K
2026-02-02	Morrissey Michael James	EVP, Head of Tech. Operations	RSU 预扣税	185	$102.67	$18.99K
2026-01-16	Mayes Patrick A	EVP & Chief Scientific Officer	限制性股票授予 (RSU)	4,218	$106.21	$447.99K
2026-01-16	Issa Mohamed Khairie	EVP, Head of Us Oncology	限制性股票授予 (RSU)	14,237	$106.21	$1.51M
2026-01-16	Heeson Lee	EVP, Head of Incyte Intl	限制性股票授予 (RSU)	8,911	-	-
2026-01-16	Trotta Matteo	EVP, GM, Dermatology Us	限制性股票授予 (RSU)	8,542	$106.21	$907.25K
2026-01-16	Tray Thomas	Principal Accounting Officer	限制性股票授予 (RSU)	2,425	$106.21	$257.56K
2026-01-20	Morrissey Michael James	EVP, Head of Tech. Operations	RSU 预扣税	429	$102.62	$44.02K
2026-01-16	Morrissey Michael James	EVP, Head of Tech. Operations	限制性股票授予 (RSU)	7,426	-	-
2026-01-16	Stein Steven H	EVP & Chief Medical Officer	限制性股票授予 (RSU)	19,932	$106.21	$2.12M
2026-01-16	Cagnoni Pablo J	President, R&d	限制性股票授予 (RSU)	28,475	$106.21	$3.02M
2026-01-07	Issa Mohamed Khairie	EVP, Head of Us Oncology	知情卖出	10,856	$109.07	$1.18M
2026-01-06	Issa Mohamed Khairie	EVP, Head of Us Oncology	RSU 预扣税	8,264	$106.66	$881.44K
2026-01-05	Stein Steven H	EVP & Chief Medical Officer	知情卖出	15,634	$101.70	$1.59M
2025-12-31	Morrissey Michael James	EVP, Head of Tech. Operations	RSU 预扣税	254	$98.77	$25.09K
2025-12-31	Stein Steven H	EVP & Chief Medical Officer	RSU 预扣税	13,292	$98.77	$1.31M
2025-12-31	Clancy Paul J	Director	限制性股票授予 (RSU)	241	$98.77	$23.8K
2025-12-31	Baker Bros. Advisors Lp	10 Percent Owner	限制性股票授予 (RSU)	328	-	-
2025-12-31	Harrigan Edmund	Director	限制性股票授予 (RSU)	245	$98.77	$24.2K